Erik Magnus Ohman, MBBS

Professor of Medicine
Member in the Duke Clinical Research Institute
Campus mail 8678A Hafs Bldg, Durham, NC 27710
Phone (919) 681-2069
Email address ohman001@mc.duke.edu

Dr. Ohman, Professor of Medicine, received medical degrees from the Royal College of Surgeons in Ireland and the National University of Ireland (1984, Fellowship 1984-1987), and completed his training in cardiology at Duke University (1987-1991), where he has remained on faculty. In 2001, he became Chief of Cardiology at the University of North Carolina at Chapel Hill, where he founded the UNC Heart Center and became its first director. In 2005 he returned to Duke to pursue his interest in advanced coronary disease as the Director of the Program for Advanced Coronary Disease. Since that time, he has been appointed to Associate Director of the Duke Heart Center, the Kent and Siri Rawson Director for the Program for Advanced Coronary Disease, and most recently, Vice-Chair of Development and Innovation in the Department of Medicine.

Dr. Ohman’s clinical and research interests include interventional cardiology and high-risk supported PCI, and treatment of patients with advanced/complex coronary disease. He has researched how to improve patient care through the use of guidelines-based therapies and adherence, and examining global cardiovascular risk and health. He has been a participant on numerous guidelines writing committees, served on the ACC/AHA oversight committee for guidelines development, and has served on the steering committees for trials on ST-elevation myocardial infarction and non-ST-elevation ACS. He is a consultant to the National Institutes of Health, and a consultant for the FDA Advisory Panel for Cardiovascular Devices. 

Dr. Ohman has published over 600 peer-reviewed papers and three books in cardiovascular medicine. He holds three U.S. patents in reperfusion therapy. He is an associate editor for the American Heart Journal and serves on the editorial boards of the Journal of the American College of Cardiology and the American Journal of Cardiology.  He is a Fellow of the Royal College of Physicians in Ireland, the Royal Society of Medicine (U.K.), the European Society of Cardiology, the Society of Cardiac Angiography and Interventions, and the American College of Cardiology. 

Education and Training

  • M.B.B.S., Royal College of Surgeons (Ireland), 1981

Publications

Samsky, Marc, Mitchell Krucoff, Andrew D. Althouse, William T. Abraham, Philip Adamson, Fernando Aguel, Seth Bilazarian, et al. “Clinical and regulatory landscape for cardiogenic shock: A report from the Cardiac Safety Research Consortium ThinkTank on cardiogenic shock.” Am Heart J 219 (January 2020): 1–8. https://doi.org/10.1016/j.ahj.2019.10.006.

PMID
31707323
Full Text

DeVore, Adam D., Eric Yow, Mitchell W. Krucoff, Matthew W. Sherwood, Linda K. Shaw, Karen Chiswell, Christopher M. O’Connor, Erik Magnus Ohman, and Eric J. Velazquez. “Percutaneous coronary intervention outcomes in patients with stable coronary disease and left ventricular systolic dysfunction.” Esc Heart Fail 6, no. 6 (December 2019): 1233–42. https://doi.org/10.1002/ehf2.12510.

PMID
31560171
Full Text

Mehran, Roxana, Usman Baber, Samin K. Sharma, David J. Cohen, Dominick J. Angiolillo, Carlo Briguori, Jin Y. Cha, et al. “Ticagrelor with or without Aspirin in High-Risk Patients after PCI.” N Engl J Med 381, no. 21 (November 21, 2019): 2032–42. https://doi.org/10.1056/NEJMoa1908419.

PMID
31556978
Full Text

Russo, Juan J., Megha Prasad, Darshan Doshi, Dimitrios Karmpaliotis, Manish A. Parikh, Ziad A. Ali, Jeffrey J. Popma, et al. “Improvement in left ventricular function following higher-risk percutaneous coronary intervention in patients with ischemic cardiomyopathy.” Catheter Cardiovasc Interv, November 6, 2019. https://doi.org/10.1002/ccd.28557.

PMID
31693292
Full Text

Burke, David A., Harun Kundi, Alexandra Almonacid, William O’Neill, Jeffrey Moses, Neal Kleiman, Simon Dixon, et al. “The Value of Left Ventricular Support in Patients With Reduced Left Ventricular Function Undergoing Extensive Revascularization: An Analysis From the PROTECT-II Randomized Trial.” Jacc Cardiovasc Interv 12, no. 19 (October 14, 2019): 1985–87. https://doi.org/10.1016/j.jcin.2019.07.050.

PMID
31601396
Full Text

Kwee, Lydia Coulter, Megan L. Neely, Elizabeth Grass, Simon G. Gregory, Matthew T. Roe, E Magnus Ohman, Keith A. A. Fox, et al. “Associations of osteopontin and NT-proBNP with circulating miRNA levels in acute coronary syndrome.” Physiol Genomics 51, no. 10 (October 1, 2019): 506–15. https://doi.org/10.1152/physiolgenomics.00033.2019.

PMID
31530226
Full Text

Ohman, E Magnus, and Ajar Kochar. “Advancing Procedural Success in Cardiogenic Shock Among Elderly Patients: How Can We Improve?” Jacc Cardiovasc Interv 12, no. 18 (September 23, 2019): 1860–62. https://doi.org/10.1016/j.jcin.2019.06.018.

PMID
31537287
Full Text

Nicolau, Jose C., Susanna R. Stevens, Hussein R. Al-Khalidi, Fabio B. Jatene, Remo H. M. Furtado, Luis A. O. Dallan, Luiz A. F. Lisboa, et al. “Does prior coronary angioplasty affect outcomes of surgical coronary revascularization? Insights from the STICH trial.” Int J Cardiol 291 (September 15, 2019): 36–41. https://doi.org/10.1016/j.ijcard.2019.03.029.

PMID
30929973
Full Text

O’Neill, William W., and E Magnus Ohman. “Letter by O'Neill and Ohman Regarding Article, "Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock: Matched-Pair IABP-SHOCK II Trial 30-Day Mortality Analysis".” Circulation 140, no. 11 (September 10, 2019): e557–58. https://doi.org/10.1161/CIRCULATIONAHA.119.040831.

PMID
31498695
Full Text

Pages